Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 685-696 of 2,301
Device study icon
UnknownNCT06320028

Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms

This study is looking at whether a digital support tool can help people with major depression or Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States
Sponsor
University of Arizona
Condition
Depression
Drug study icon
CompletedNCT05870540

BPL-003 Efficacy and Safety for treatment-resistant depression

This study is completed in the United States, in Australia, in the United Kingdom, .... It is testing BPL-003 Efficacy and Safety for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Beckley Psytech Limited
Condition
Depression
Device study icon
Active Not RecruitingNCT01984710

Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 25 Years to 70 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
Drug study icon
WithdrawnNCT03290963

Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
William V. Bobo, M.D.
Condition
Depression
Behavioral study icon
CompletedNCT05913401

Exercise to Augment TMS in Those With Treatment Resistant Depression

This study is looking at care and outcomes for people with Treatment Resistant Depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Depression
Drug study icon
CompletedNCT06620042

FMRI of Patients Receiving IV Ketamine for Treatment Resistant Depression in bipolarity

This study exists to learn from real-world information that can show how brain scans or other body measurements fits into care. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Brian Barnett
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT06138691

KET-RO Plus RO DBT for Treatment Resistant Depression

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression
Drug study icon
CompletedNCT02577250

Ketamine Infusions for PTSD and Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, PTSDDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Minneapolis Veterans Affairs Medical Center
Condition
Depression, PTSD
Device study icon
CompletedNCT03428828

Neurofeedback for Treatment Resistant Depression

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 55 Years
Countries
United States
Sponsor
Kymberly Young
Condition
Depression
Drug study icon
CompletedNCT05066672

NV-5138 for treatment-resistant depression

This study is completed in the United States. It is testing NV-5138 for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Navitor Pharmaceuticals, Inc.
Condition
Depression
Device study icon
CompletedNCT03953417

Accelerated Theta Burst in Treatment-Resistant Depression in bipolarity

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceFrom 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Drug study icon
Active Not RecruitingNCT06303739

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

This study is looking at whether questionnaires and follow-up can help people with Refractory Depression or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.